Announced Tue, 21 Jul · 16:26 IST
Q1 FY27 results: Revenue and profit decline year-on-year
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹794.00
prior close
₹750.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.8+1.4-0.4+0.1-1.5-3.1-0.6———————
Up moveDown movePending
AI summary
Anthem Biosciences Q1 FY27 standalone revenue fell to Rs 3,838.42 Mn from Rs 5,380.11 Mn YoY, down about 28.6%. Standalone profit dropped to Rs 1,020.09 Mn from Rs 1,483.40 Mn. Consolidated revenue was Rs 4,182.18 Mn (vs Rs 5,402.09 Mn) and consolidated profit was Rs 1,199.41 Mn (vs Rs 1,357.91 Mn). Auditor K.P. Rao and Co. gave an unmodified review opinion on both results. Company also allotted 16.7 lakh shares under ESOP Scheme 2024 during the quarter.
Likely market impact
Sharp YoY revenue and profit decline may weigh on stock sentiment despite clean audit opinion and continued profitability.